Relationship between percent GATA2+ blasts and survival in adult AML
| AML group . | OS (mos) Median (95% CI) . | GATA2 hazard ratio (95% CI)∗ . | P value . |
|---|---|---|---|
| Overall (n = 68) | 8.4 (5.4-12.9) | 0.93 (0.55-1.50) | .768 |
| Curative intent | |||
| No (n = 41) | 4.0 (2.6-5.8) | 1.13 (0.57-2.13) | .720 |
| Yes (n = 27) | 21.0 (12.7, —) | 0.80 (0.29-1.89) | .619 |
| Allogeneic HSCT | |||
| No (n = 46) | 4.1 (2.7-8.4) | 1.00 (0.49-1.96) | .997 |
| Yes (n = 22) | 17.7 (10.3, —) | 0.88 (0.34-1.94) | .759 |
| AML group . | OS (mos) Median (95% CI) . | GATA2 hazard ratio (95% CI)∗ . | P value . |
|---|---|---|---|
| Overall (n = 68) | 8.4 (5.4-12.9) | 0.93 (0.55-1.50) | .768 |
| Curative intent | |||
| No (n = 41) | 4.0 (2.6-5.8) | 1.13 (0.57-2.13) | .720 |
| Yes (n = 27) | 21.0 (12.7, —) | 0.80 (0.29-1.89) | .619 |
| Allogeneic HSCT | |||
| No (n = 46) | 4.1 (2.7-8.4) | 1.00 (0.49-1.96) | .997 |
| Yes (n = 22) | 17.7 (10.3, —) | 0.88 (0.34-1.94) | .759 |
AML, acute myeloid leukemia; CI, confidence interval; HSCT, hematopoietic stem cell transplantation; OS, overall survival.
Hazard ratio for a 1 interquartile range increase in percent GATA2+ blasts (from 5%-60%).